Evidence map›Paper›PMID 41677821›Full record

ReviewGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2026

A literature review of macular holes in age-related macular degeneration: insights into the pathogenesis, prognosis and surgical outcomes.

Evita Evangelia Christou, Tsveta Ivanova, Niall Patton, George Moussa, Peter Kiraly, Fernando J Huelin, Robert E MacLaren, Assad Jalil

Abstract readReview
PubMed Publisher
In one paragraph

Review in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Evita Evangelia ChristouManchester Royal Eye Hospital, Manchester University NHS Foundation Trust, Manchester, UK. evitachristou@gmail.com.ORCID 0000-0002-7959-4854
Tsveta IvanovaManchester Royal Eye Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
Niall PattonManchester Royal Eye Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
George MoussaManchester Royal Eye Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
Peter KiralyManchester Royal Eye Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
Fernando J HuelinManchester Royal Eye Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
Robert E MacLarenOxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Assad JalilManchester Royal Eye Hospital, Manchester University NHS Foundation Trust, Manchester, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pathogenesis of macular holes in eyes with background of age-related macular degeneration (AMD) and the potential causative relationship between these entities remains unclear. In this narrative review, we aim to explore the intricate relationship between the formation of macular holes, both full-thickness and lamellar, and neovascular / non-subtype of AMD. A literature search was performed using the National Center for Biotechnology Information (NCBI) PubMed database, and studies published up to March 2025 were included. We summarize the current evidence on AMD-associated macular holes, and provide insights into the underlying pathophysiological mechanisms, prevalence, prognosis and surgical outcomes. Research to date suggests that macular holes can uncommonly develop in eyes with coexistent AMD, with a contributing role of tractional and degenerative component in their development and progression. Intravitreal anti vascular endothelial growth factor injections for neovascular AMD have been implicated in macular hole formation. Surgical intervention with vitrectomy and internal limiting membrane peel remains the optimal proven method for restoring vision in macular holes, however comprehensive evaluation and individualized management approaches may optimize anatomical and functional outcomes in this patient population. Recent findings underscore that there is no evidence yet of a benefit to using stem cell therapy in macular holes with coexistent AMD. This review sheds light on the postulated pathogenesis of AMD-associated macular holes, discusses practical aspects of prognostic prediction and examines appropriate management options. Current evidence needed to guide clinical practice is both limited and often contradictory, and further studies are warranted to elucidate these findings.

Indexed as

Macular DegenerationRetinal PerforationsVisual AcuityVitrectomyWet Macular DegenerationAngiogenesis InhibitorsHumansPrognosisTomography, Optical CoherenceAngiogenesis InhibitorsAge related macular degenerationFull thickness macular holeIntravitreal anti-VEGFLamellar macular holeVitrectomy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.